We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
-0.2%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$147B
AUM Growth
+$7.72B
(+5.5%)
Cap. Flow
+$9.46B
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
41.95%
Holding
4,221
New
328
Increased
2,776
Reduced
891
Closed
131
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$888M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$700M |
| 3 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$408M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$338M |
| 5 |
Vanguard Russell 1000 Value ETF
VONV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$248M |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$41.4M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$39.9M |
| 4 |
SCHV
Schwab US Large-Cap Value ETF
SCHV
|
+$34.6M |
| 5 |
Schwab US Mid-Cap ETF
SCHM
|
+$32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.02% |
| 2 | Financials | 3.7% |
| 3 | Industrials | 2.22% |
| 4 | Healthcare | 2.17% |
| 5 | Consumer Discretionary | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4026
Pulmonx
LUNG
$50.3M
| $29.3K | ﹤0.01% |
22,731
+3,698
| +19% | +$6.11K |
|
4027
Galectin Therapeutics
GALT
$229M
| $29.3K | ﹤0.01% |
10,485
-780
| -7% | -$2.37K |
|
|
SEV
4028
Aptera Motors
SEV
$66.8M
| $28.9K | ﹤0.01% |
+10,917
| New | +$29.1K |
|
|
NRO
4029
Neuberger Real Estate Securities Income Fund Inc
NRO
$195M
| $28.6K | ﹤0.01% |
10,081
-636
| -6% | -$1.9K |
|
|
QNC
4030
Quantum eMotion
QNC
$456M
| $27.8K | ﹤0.01% |
+12,130
| New | +$35.4K |
|
4031
BRC Inc
BRCC
$129M
| $27.6K | ﹤0.01% |
35,546
+12,538
| +54% | +$10.6K |
|
4032
Claros Mortgage Trust
CMTG
$307M
| $27.3K | ﹤0.01% |
11,473
-10,148
| -47% | -$26.3K |
|
4033
Microvast
MVST
$274M
| $26.4K | ﹤0.01% |
17,608
-7,889
| -31% | -$19K |
|
4034
Getty Images
GETY
$179M
| $26.3K | ﹤0.01% |
33,192
+12,973
| +64% | +$13.1K |
|
4035
CALL
Coeur Mining
CDE
$15.7B
| $25.6K | ﹤0.01% |
+20,000
| New | +$435K |
|
|
INFQ
4036
CALL
Infleqtion Inc
INFQ
$1.99B
| $25.5K | ﹤0.01% |
+20,000
| New | +$228K |
|
4037
Coherus Oncology
CHRS
$217M
| $24.9K | ﹤0.01% |
+14,744
| New | +$26.2K |
|
4038
Prairie Operating Co
PROP
$77.9M
| $24.7K | ﹤0.01% |
+12,177
| New | +$22K |
|
4039
PUT
Cincinnati Financial
CINF
$28B
| $24.6K | ﹤0.01% |
+15,000
| New | +$2.44M |
|
4040
Douglas Elliman
DOUG
$158M
| $23.4K | ﹤0.01% |
14,290
+1,919
| +16% | +$4.45K |
|
|
RUMBW
4041
RUM Group Inc Warrant
RUMBW
$13M
| $23K | ﹤0.01% |
21,500
+10,000
| +87% | +$15.1K |
|
4042
Cognition Therapeutics
CGTX
$82.5M
| $22.9K | ﹤0.01% |
30,204
+200
| +0.7% | +$233 |
|
4043
Marker Therapeutics
MRKR
$21.7M
| $22.5K | ﹤0.01% |
17,312
| – | – |
|
|
STKE
4044
Sol Strategies Inc
STKE
$40.3M
| $22.2K | ﹤0.01% |
+22,510
| New | +$35.2K |
|
4045
Lineage Cell Therapeutics
LCTX
$259M
| $21.6K | ﹤0.01% |
13,685
-4,522
| -25% | -$7.63K |
|
4046
Cardlytics
CDLX
$22.1M
| $19.4K | ﹤0.01% |
1,852
| – | – |
|
4047
SKYX Platforms
SKYX
$156M
| $19.4K | ﹤0.01% |
+17,295
| New | +$36.1K |
|
4048
eHealth
EHTH
$43.2M
| $18.6K | ﹤0.01% |
+14,382
| New | +$33.3K |
|
4049
Biomea Fusion
BMEA
$89.7M
| $18.4K | ﹤0.01% |
12,000
| – | – |
|
4050
Hain Celestial
HAIN
$49M
| $17.2K | ﹤0.01% |
24,690
+13,775
| +126% | +$12.8K |
|
Similar funds
Creative Planning's Q1 2026 Portfolio in Review
As of Q1 2026, Creative Planning held 4,221 positions worth $147B, up 5.5% from $140B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $9.46B of net new capital in Q1 2026, opening 328 new positions and adding to 2,776 existing holdings. Its largest new stake was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 8.4% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $248M trimmed.
- Creative Planning's largest Q1 2026 buy was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
- Creative Planning added most to Vanguard Short-Term Bond ETF in Q1 2026, an estimated $888M increase.
- Creative Planning's biggest Q1 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $248M.
- Creative Planning fully exited CyberArk in Q1 2026, selling an estimated $9.29M.
- Creative Planning's ten largest holdings make up 42% of its $147B portfolio in Q1 2026.
- Creative Planning opened 328 new positions and closed 131 in Q1 2026.
- Creative Planning's portfolio value rose 5.5% quarter-over-quarter to $147B.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.